🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06307262
Recruiting Observational

European Registry of Transcatheter Repair for Tricuspid Regurgitation

NCT06307262 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2023-10-23
Last updated
2024-03-15

Condition(s) studied

Tricuspid RegurgitationValvular Heart DiseaseHeart Failure

Investigational drug(s) / intervention(s)

T-TEER

T-TEER: T-TEER using the PACAL or TriClip device

Study summary

To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients treated with one of the following transcatheter devices for TV repair or replacement: PASCAL, TriClip, TricValve, Evoque, LuX-Valve * Age ≥ 18 years

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
LMU Klinikum Munich Bavaria Recruiting

More LMU Klinikum trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06307262 on ClinicalTrials.gov ↗ ← All trials in Germany